πŸ‡ΊπŸ‡Έ

Moderna just finished recruiting 30,000 people for its coronavirus vaccine trial. One graph reveals how the biotech slowed down its research to recruit more minorities.

Credit: Business Insider- Published on October 22, 2020
Minorities make up 37% of the study, but that percentage was on track to be much lower until the company slowed enrollment and closed trial sites.
Advertisement

Video credit: Wochit
Published on October 23, 2020 -  00:32
AstraZeneca's Coronavirus Vaccine Trial Can Continue In The US
AstraZeneca and the University of Oxford got the go-ahead to restart their US coronavirus vaccine trials. The late-stage trial was stopped due to a possible adverse reaction in one of the participants. On September 6 AstraZeneca reported a "suspected serious adverse reaction". According to Business Insider, the reaction occurred in a UK-based participant. The UK resumed clinical trials for AstraZeneca and the University of Oxford vaccines in September. The trials in Japan resumed earlier this month.

You are here


Related videos from verified sources

How the AstraZeneca-Oxford COVID Vaccine Works 01:58
Credit: TomoNews US - Published 19 hours ago 


Doctors Say CDC Should Warn People About COVID-19 Vaccine Side Effects 01:22
Credit: Wibbitz Top Stories - Published 1 day ago 


AstraZeneca, 3rd Major COVID-19 Vaccine, Shown to Be Effective and Cheaper 01:10
Credit: Wibbitz Top Stories - Published 2 days ago 


You might like